Exelixis, Inc. drugs

2 results
  • cabometyx - cabozantinib tablet

    (Cabozantinib)
    Exelixis, Inc.
    Cabometyx treats advanced renal cell carcinoma (alone or with nivolumab), hepatocellular carcinoma after sorafenib, and locally advanced or metastatic differentiated thyroid cancer or neuroendocrine tumors (pancreatic and extra-pancreatic) in adults and patients 12 and older after prior therapy.